DENTSPLY SIRONA $XRAY

Health Care · NASDAQ

$8.29
-0.20 (-2.36%)
As of Nov 20, 2026, 4:05 PM EST · cached
Price history
Loading chart…
Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Nov 6, 2026, the first target we tracked for XRAY.

DENTSPLY SIRONA (XRAY) is trading down at $8.29 (-2.36%) on NASDAQ, as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

Analyst price targets on XRAY

One firm's current price target on DENTSPLY SIRONA: $14 — 69% above the current $8.29. Each is tracked to its date and scored the same way a member's call is.

1 target, newest first. Open a row for its source and scoring.

DateNov 6, 2026 FirmBank of America RatingBuy · lowers Targetat $9.46 · $14 +48% Horizonby Nov 2027 StatusOpen

Entry price $9.46, the close nearest Nov 6, 2026, when the target was reported; the target is +48% from it.

Horizon No horizon stated, so it is tracked over the 12-month default, to Nov 2027.

Scoring Open: judged on the close on Nov 6, 2027.

Source BofA cuts Dentsply Sirona stock price target on guidance reset Investing.com · Nov 6, 2026 · opens the publisher's site
BofA Securities lowered its price target on Dentsply Sirona shares (NASDAQ:XRAY) to $14 from $17 while maintaining a Buy rating on Friday.

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. “At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

DENTSPLY SIRONA revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)
$4.23B$1.34B−$1.55BFY2016 revenue: $3.75BFY2016 net income: $429.9M · Net margin 11.5%'16FY2017 revenue: $3.99BFY2017 net income: −$1.55B · Net margin −38.8%'17FY2018 revenue: $3.99BFY2018 net income: −$1.01B · Net margin −25.4%'18FY2019 revenue: $4.02BFY2019 net income: $256.0M · Net margin 6.4%'19FY2020 revenue: $3.34BFY2020 net income: −$73.0M · Net margin −2.2%'20FY2021 revenue: $4.23BFY2021 net income: $411.0M · Net margin 9.7%'21FY2022 revenue: $3.92BFY2022 net income: −$950.0M · Net margin −24.2%'22FY2023 revenue: $3.96BFY2023 net income: −$132.0M · Net margin −3.3%'23FY2024 revenue: $3.79BFY2024 net income: −$910.0M · Net margin −24.0%'24FY2025 revenue: $3.68BFY2025 net income: −$598.0M · Net margin −16.3%'25−10%0%10%20%30%FY2016 net margin: 11.5%FY2017 net margin: −38.8% (off the scale, which stops at −11.0%)FY2018 net margin: −25.4% (off the scale, which stops at −11.0%)FY2019 net margin: 6.4%FY2020 net margin: −2.2%FY2021 net margin: 9.7%FY2022 net margin: −24.2% (off the scale, which stops at −11.0%)FY2023 net margin: −3.3%FY2024 net margin: −24.0% (off the scale, which stops at −11.0%)FY2025 net margin: −16.3% (off the scale, which stops at −11.0%)
DENTSPLY SIRONA annual financial statements
FY2016Dec 2016FY2017Dec 2017FY2018Dec 2018FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$3.75B$3.99B$3.99B$4.02B$3.34B$4.23B$3.92B$3.96B$3.79B$3.68B
Growth (year over year)+40.0%+6.6%−0.2%+0.9%−17.0%+26.7%−7.3%+1.1%−4.3%−3.0%
Gross profit$2.00B$2.19B$2.07B$2.16B$1.66B$2.35B$2.13B$2.09B$1.96B$1.84B
Gross margin53.4%54.8%51.9%53.8%49.6%55.5%54.2%52.6%51.6%50.0%
Operating income$454.7M−$1.56B−$958.0M$353.0M−$3.00M$608.0M−$937.0M−$85.0M−$879.0M−$422.0M
Operating margin12.1%−39.1%−24.0%8.8%−0.1%14.4%−23.9%−2.1%−23.2%−11.5%
Net income$429.9M−$1.55B−$1.01B$256.0M−$73.0M$411.0M−$950.0M−$132.0M−$910.0M−$598.0M
Net margin11.5%−38.8%−25.4%6.4%−2.2%9.7%−24.2%−3.3%−24.0%−16.3%
EPS (diluted)$1.94−$6.76−$4.51$1.14−$0.33$1.87−$4.41−$0.62−$4.48−$3.00
Balance sheet
Cash and equivalents$383.9M$320.6M$309.6M$405.0M$438.0M$339.0M$365.0M$334.0M$272.0M$326.0M
Total assets$11.6B$10.4B$8.69B$8.60B$9.35B$9.24B$7.64B$7.37B$5.75B$5.43B
Total liabilities$3.43B$3.75B$3.55B$3.51B$4.42B$4.24B$3.83B$4.08B$3.81B$4.09B
Long-term debt$1.51B$1.61B$1.56B$1.43B$1.98B$1.91B$1.83B$1.80B$1.59B$2.02B
Shareholders' equity$8.11B$6.62B$5.12B$5.09B$4.93B$5.00B$3.81B$3.29B$1.94B$1.34B
Cash flow
Operating cash flow$563.4M$601.9M$500.0M$639.0M$649.0M$657.0M$517.0M$377.0M$461.0M$235.0M
Capital expenditure$125.0M$144.3M$183.0M$123.0M$87.0M$142.0M$149.0M$149.0M$180.0M$131.0M
Free cash flow$438.4M$457.6M$317.0M$516.0M$562.0M$515.0M$368.0M$228.0M$281.0M$104.0M
Dividends paid$64.6M$78.3M$79.0M$81.0M$88.0M$92.0M$104.0M$116.0M$126.0M$128.0M
Share buybacks$813.9M$401.4M$250.0M$260.0M$140.0M$200.0M$150.0M$300.0M$250.0M$0

From DENTSPLY SIRONA's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

DENTSPLY SIRONA in the news

Nov 16, 2026 TradingView Dental equipment & technology stocks Q3 highlights: Dentsply Sirona
Nov 6, 2026 Investing.com BofA cuts Dentsply Sirona stock price target on guidance reset Target

About DENTSPLY SIRONA

Headquarters
Charlotte, North Carolina From SEC filings, Oct 2026

More Health Care stocks

Browse all companies →